Top article

Smoking cessation aid may increase heart risks

The smoking cessation aid varenicline (Chantix, Pfizer) may increase the risk of cardiovascular events in adults with cardiovascular disease, according to a recent FDA safety announcement. » More

Continuing Education

New CPE Series: December activity available now

Welcome to the fourth activity of our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The December activity will cover insulin therapy for diabetes care management.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Today's Headlines

Industry-sponsored studies report favorable findings

Industry-sponsored studies are more likely to report favorable findings on the sponsor's drug or device, according to a recent literature review. Healthcare professionals who rely on systematic reviews to aid decision-making should be aware of this industry influence on conclusions. » More

Aspirin resistance is rare

Pharmacological resistance to aspirin is rare. Researchers at the University of Pennsylvania in Philadelphia said they could not identify one case of true drug resistance, according to the study published online Dec. 4 in the journal Circulation. » More

Tamiflu available for kids 2 weeks and older

Oseltamivir (Tamiflu) can now be used to treat children who are 2 weeks of age and older, according to an FDA press release.
» More

TAKE OUR SURVEY

Are you counseling more oncology patients to help them with their medication regimens?

- Yes
- No

Click Here to let us know.

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out too

• Letters from readers

• NECC disaster spinal infections persist

• FDA approves constipation drug

• Better control of high BP in U.S. adults

Voices

Anticoagulation Update

JP at Large: Loaded doesn't kill you

View from the Zoo: Goal of improved health may fall short despite increased pharmacy workload

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News and analysis

Meetings and Events